Rovii Biotech

Rovii Biotech is a specialized life science tools company focused on the development of microfluidic technologies and digital PCR (dPCR) systems. The company provides high-precision instruments for absolute nucleic acid quantification, which are utilized in liquid biopsy, single-cell analysis, and pathogen detection. Their core technology, the DropX platform, leverages droplet microfluidics to offer high sensitivity and throughput for clinical and research applications. Rovii Biotech aims to advance precision medicine by making complex molecular analysis more accessible and efficient. The company serves a global market, providing solutions for oncology, infectious disease monitoring, and reproductive health.